Announced
Completed
Financials
Tags
Private Equity
Cross Border
Private
Medical Equipment
surgical devices
France
Single Bidder
Friendly
Completed
Minority
Acquisition
Venture Capital
Synopsis
Cathay Capital, a private equity firm, led a $50m Series D funding round in TISSIUM, a developer of biodegradable sealants and adhesives for surgical-wound closure, with participation from Fonds Stratégique des Transitions, Merieux Developpement, Credit Mutuel Innovation, and Sofinnova Partners. "With the closing of our Series D financing round, TISSIUM is well-positioned to finance the commercialization of its first products. This funding significantly bolsters our ability to move with speed towards our goal of enhancing tissue reconstruction for patients. We look forward to continuing our work to bring innovation in the space and develop products that make a difference in patients’ lives,” Christophe Bancel, TISSIUM CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.